Chemically Induced Adrenocortical Lesions

  • John T. Yarrington
Part of the Monographs on Pathology of Laboratory Animals book series (LABORATORY)

Abstract

As a result of increasing toxicological testing, examples of chemically induced adrenocortical degeneration are becoming frequently documented in contrast to rarely reported spontaneous lesions of laboratory animals (Capen et al. 1975; Anderson and Capen 1978). Compounds such as glucocorticoids (Sasano et al. 1966; Purjesz et al. 1964), 7,12-dimethylbenzanthracene (Murad et al. 1973), aminoglutethimide (Camacho et al. 1967; Malendowicz 1972), spironolactone (Fisher and Horvat 1971), o,p′-DDD, the active isomer of technical grade DDD (Nelson and Woodard 1949; Hennigar et al. 1964), α-(1,4-dioxido-3-methyl-quinoxalin-2-yl-)-N-methylnitrone (DMNM) (Yarrington et al. 1981, to be published), amphenone (Hertz et al. 1955) and 1,1′ thiodiethylideneferrocene (Yarrington, 1981 unpublished observations) can inhibit steroidogenesis while causing morphologically degenerative changes of the adrenal cortex. Some of these so-called adrenocorticolytic compounds which cause widespread adrenal cortical degenerations have a species-specific toxicity such as o,p′-DDD in the dog and 7,12-dimethylbenzanthracene in the rat (Nelson and Woodard 1949; Murad et al. 1973). In contrast, chemicals like DMNM and 1,1′ thiodiethylidene-ferrocene cause adrenal cortical lesions in numerous species, including dogs, rats, and monkeys (Yarrington 1981, unpublished observations; Yarringtion et al. 1981).

Synonyms

Chemically induced adrenocorticolysis adrenal cortical necrosis adrenal cortical degeneration 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abbott EC, Monkhouse FC, Steiner JW, Laidlaw JC (1966) Effect of a sulfated mucopolysaccharide (R01–8307) on the zona glomerulosa of the rat adrenal gland. Endocrinology 78: 651–654PubMedCrossRefGoogle Scholar
  2. Anderson MP, Capen CC (1978) The endocrine system. In: Benirschke K, Garner FM, Jones TC (eds) Pathology of laboratory animals, vol 1. Springer, Berlin Heidelberg New York, Chapter 6Google Scholar
  3. Camacho AM, Cash R, Brough AJ, Wilroy RS (1967) Inhibition of adrenal steroidogenesis by amino-glutethimide and the mechanism of action. JAMA 202: 114–120CrossRefGoogle Scholar
  4. Capen CC, Belshaw BE, Martin SL (1975) Endocrine disorders. In: Ettinger SJ (ed) Textbook of veterinary internal medicine, Sect 10, Diseases of the dog and cat. Saunders, Philadelphia pp 1351–1452Google Scholar
  5. Cohen MP (1968) Aminoglutethimide inhibition of adrenal desmolase activity. Proc Soc Exp Biol Med 127: 1086–1090PubMedGoogle Scholar
  6. Dexter RN, Fishman LM, Ney RL, Liddle GW (1967) Inhibition of adrenal corticosteroid synthesis by aminoglutethimide: Studies of the mechanism of action. J Clin Endocrino 127: 473–480CrossRefGoogle Scholar
  7. Dietert SE, Scallen TJ (1969) An ultrastructural and biochemical study of the effects of three inhibitors of cholesterol biosynthesis upon murine adrenal gland and testes. J Cell Biol 40: 44–60PubMedCrossRefGoogle Scholar
  8. Fisher ER, Horvat B (1971) Experimental production of so- called spironolactone bodies. Arch Pathol 91: 471–478PubMedGoogle Scholar
  9. Hart MM, Swackhamer ES, Straw JA (1971) Studies on the site of action of o,p’-DDD in the dog adrenal cortex. II. TPNH- and corticosteroid precursor-stimulation of o,p’-DDD inhibited steroidogenesis. Steroids 17: 575–586PubMedCrossRefGoogle Scholar
  10. Hennigar GR, Fleckner RA, Golding MR (1964) Degeneration and regeneration of the adrenal cortex following administration of DDD (2,2-bis (parachlorophenyl)-1,1 dichlorethane. Bull NY Acad Med 40: 161–166Google Scholar
  11. Hertz R, Tullner WW, Schricker JA, Dhyse FG, Hallman LF (1955) Studies on amphenone and related compounds. Recent Prog Horm Res 11: 119–147Google Scholar
  12. Holloszy J, Eisenstein AB (1961) Effect of triparanol (MER/ 29) on corticosterone secretion by rat adrenals. Proc Soc Exp Biol Med 107: 347–349PubMedGoogle Scholar
  13. Kaminsky N, Luse S, Hartroft P (1962) Ultrastructure of adrenal cortex of the dog during treatment with DDD. J Natl Cancer Inst 29: 127–159PubMedGoogle Scholar
  14. Liddle GW (1974) The adrenal cortex. In: Williams RH (ed) Textbook of endocrinology. Saunders, Philadelphia, pp 233–283Google Scholar
  15. Luse S (1967) Fine structure of the adrenal cortex. In: Eisenstein AB (ed) The adrenal cortex. Little, Brown and Co., Boston pp 1–69Google Scholar
  16. Malendowicz LK (1972) Steatotic degeneration of rat adrenocortical cells after treatment with aminoglutethimide. Acta Histochem (Jena) 43: 350–360Google Scholar
  17. Marek J, Pfeifer U (1971) Microthrombi as a partial cause of adrenal damage due to hexadimethrine bromide (Polybrene). Verh Dtsch Ges Pathol 55: 706–709PubMedGoogle Scholar
  18. Marek J, Pfeifer U, Motlik K (1973) Ultrastructure of the protein-containing vacuoles and hyaline droplets in rat adrenocortical cells following Polybrene. Virchows Arch [Cell Pathol] 14: 273–283Google Scholar
  19. Mitani F (1979) Cytochrome P450 in adrenocortical mitochondria. Mol Cell Biochem 24: 21–44PubMedCrossRefGoogle Scholar
  20. Moore NA, Callas G (1975) Observations on the fine structure of propylthiouracil induced “brown degeneration” in the zona reticularis of mouse adrenal cortex. Anat Rec 183: 293–302PubMedCrossRefGoogle Scholar
  21. Murad TM, Leibach J, Von Haam E (1973) Latent effect of DMBA on adrenal glands of Sprague-Dawley rats: an ultrastructural study. Exp Mol Pathol 18: 305–315PubMedCrossRefGoogle Scholar
  22. Nelson AA, Woodard G (1949) Severe adrenal cortical atrophy (cytotoxic) and hepatic damage produced in dogs by feeding 2,2-bis (parachlorophenyl)-1,1-dichlorethane (DDD or TDE). Arch Pathol 48: 387–394Google Scholar
  23. Powers JM, Hennigar GR, Grooms G, Nichols J (1974) Adrenal cortical degeneration and regeneration following administration of DDD. Am J Pathol 75: 181–194PubMedGoogle Scholar
  24. Purjesz I, Sturcz J, Huttner I (1964) The effect of chronic prolonged water loading on prednisolone induced adrenocortical atrophy. Experimentia 20: 688–689CrossRefGoogle Scholar
  25. Racela A Jr, Azarnoff D, Svoboda D (1969) Mitochondria) cavitation and hypertrophy in rat adrenal cortex due to aminoglutethimide. Lab Invest 21: 52–60PubMedGoogle Scholar
  26. Rhodin JAG (1971) The ultrastructure of the adrenal cortex of the rat under normal and experimental conditions. J Ultrastruct Res 34: 23–71PubMedCrossRefGoogle Scholar
  27. Sasano N, Ichinoe F, Hirano K (1966) Histological and enzyme histochemical studies on adrenocortical atrophy induced by hydrocortisone, dexamethasone and paramethasone. Folia Endocrinol Jpn 41: 1432–1437Google Scholar
  28. Steinberg D, Avigan J (1960) Studies of cholesterol biosynthesis. II. The role of desmosterol in the biosynthesis of cholesterol. J Biol Chem 235: 3127–3129Google Scholar
  29. Temple TE, Liddle GW (1970) Inhibitors of adrenal steroid biosynthesis. Ann Rev Pharmacol 10: 199–218PubMedCrossRefGoogle Scholar
  30. Vilar O, Tullner WW (1959) Effects of o,p’-DDD on histology and 17-hydroxycorticosteroid output of the dog adrenal cortex. Endocrinology 65: 80–86PubMedCrossRefGoogle Scholar
  31. Volk TL, Scarpelli DG (1964) Alterations of fine structure of the rat adrenal cortex after the administration of triparanol. Lab Invest 13: 1205–1214PubMedGoogle Scholar
  32. Yarrington JT (1981) Unpublished observations. 1981Google Scholar
  33. Yarrington JT, Huffman KW, Gibson JP (1981) Adrenocortical degeneration in dogs, monkeys and rats treated with a(1,4-dioxido-3-methylquinoxalin-2-y1)-N-methylnitrone. Toxicol Lett 8: 229–234PubMedCrossRefGoogle Scholar
  34. Yarrington JT, Loudy DE, Sprinkle DJ, Gibson JP, Wright GL, Johnston JO (to be published) Degeneration of the rat and canine adrenal cortex caused by a-(1,4-dioxido-3-methylquinoxalin-2-yl)-N-methylnitrone (DMNM). J Environ Pathol ToxicolGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1983

Authors and Affiliations

  • John T. Yarrington

There are no affiliations available

Personalised recommendations